[-] Show simple item record

dc.contributor.authorGallimore, Caseyen_US
dc.date.issued2008-12
dc.description.abstractWhile some small differences have been found between agents, selective serotonin reuptake inhibitors (SSRIs) and non-SSRI second-generation antidepressants generally have similar efficacy and discontinuation rates when used to treat depression. However, side effect profiles differ by agent: more blood pressure elevation with venlafaxine, more weight gain with mirtazapine, and less sexual dysfunction with bupropion. (SOR A, based on systematic reviews and meta-analyses.)en_US
dc.identifier.citationEvidence Based Practice 11(12): 06-07.en_US
dc.identifier.urihttp://hdl.handle.net/10355/7402
dc.publisherFamily Physicians Inquiries Networken_US
dc.relation.ispartofEvidence Based Practice 11(12): 06-07.en_US
dc.relation.ispartofcollectionEvidence Based Practice, 2008en_US
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. Evidence Based Practice.en_US
dc.relation.ispartofseriesHelp Desk Answersen_US
dc.subject.lcshDrugs -- Side effectsen_US
dc.subject.lcshDepression, Mental -- Treatmenten_US
dc.titleWhat is the relative effectiveness and safety of second-generation antidepressants?en_US
dc.typeArticleen_US


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record